Form 4 for ASTH Astrana Health, Inc.
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0001104659-25-110504 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-12 | 2025-11-07 | ASTH | Kitayama Mitchell W | Dir | M - OptEx | $18.20 | +12.0K | 27.8K | +76% | +$218.4K |
| D | 2025-11-12 | 2025-11-07 | ASTH | Kitayama Mitchell W | Dir | M - OptEx | $0.00 | -12.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-07 | M | A | 12,000 | $18.20 | 27,846 | D | — | — | (F1) Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
| 2 | Derivative | Stock Option (right to buy) | 2025-11-07 | M | D | 12,000 | $0.00 | 0 | D | $18.20 · — to 2025-11-11 | 12,000 Common Stock | (F2) These stock options were fully vested and exercisable. |